Aziz Shaibani

机构：Baylor College of Medicine, Texas Nerve and Paralysis Institute · ORCID：0000-0001-9828-0861

发表论文 181 篇 · 总被引 3644 次 · h-index 30

代表论文

• Placebo and nocebo effects and mechanisms associated with pharmacological interventions: an umbrella review (2023 · BMJ Open · 被引 38)
• Efficacy and Safety of Subcutaneous Abatacept Plus Standard Treatment for Active Idiopathic Inflammatory Myopathy: Phase 3 Randomized Controlled Trial (2024 · Arthritis & Rheumatology · 被引 17)
• A randomized, double-blind, placebo-controlled study of histone deacetylase type 6 inhibition for the treatment of painful diabetic peripheral neuropathy (2023 · PAIN Reports · 被引 9)
• Sertraline‐Associated Riboflavin‐Responsive Lipid Storage Myopathy: Report of Two Case (2025 · Muscle & Nerve · 被引 4)
• Placebo nonresponders: An experimental investigation on their unreliability over time (2025 · Journal of Pain · 被引 4)
• Efficacy and safety of cemdisiran siRNA in myasthenia gravis (NIMBLE): a double-blind, randomised, placebo-controlled, phase 3 trial (2026 · The Lancet · 被引 2)